What question did this study set out to answer?

To evaluate whether reported reductions in 30-day postoperative pulmonary complications with sugammadex compared to neostigmine reflect true pharmacological effects or methodological confounding.

August 16, 2026Anaesthesia

Sugammadex and postoperative pulmonary complications after upper gastrointestinal endoscopy

View Full Paper

Ask AI

Bookmark

Authors

DPDaniel PearceUniversity of California, Los Angeles KGKimia Tiffany GhasemianUniversity of California, Los Angeles AJAlexandre JoostenUniversity of California, Los Angeles

Discussion

Member takes

Implication

Critical appraisal evaluates postoperative pulmonary outcomes following endoscopy, indicating that observed benefits of sugammadex over neostigmine may reflect residual confounding.

Key Points

To evaluate whether reported reductions in 30-day postoperative pulmonary complications with sugammadex compared to neostigmine reflect true pharmacological effects or methodological confounding.
Critical appraisal of an observational database study comparing sugammadex and neostigmine following upper gastrointestinal endoscopy.
Evaluated primary endpoints defined as mechanical ventilation or reintubation within 30 days alongside biological plausibility windows and unmeasured confounders.
The 30-day outcome window likely captures late hospital-acquired complications and disease progression rather than drug-related residual neuromuscular blockade, which is clinically relevant within 24 to 72 hours.
A reported reduction in mechanical ventilation occurred without corresponding differences in aspiration events, hypoxaemia, non-invasive ventilation, or mortality.
Omission of quantitative neuromuscular monitoring and train-of-four recovery data leaves substantial potential for residual confounding in the comparative analysis.

Cite This Study

Pearce et al. (2026) studied this question.

synapsesocial.com/papers/6a8178fcf2fb91fc834ac21f https://doi.org/10.1111/anae.70351

View Full Paper

Ask AI

Bookmark

Implication

Critical appraisal evaluates postoperative pulmonary outcomes following endoscopy, indicating that observed benefits of sugammadex over neostigmine may reflect residual confounding.

Sugammadex and postoperative pulmonary complications after upper gastrointestinal endoscopy

Discussion

Member takes

Implication

Key Points

Cite This Study

Sugammadex and postoperative pulmonary complications after upper gastrointestinal endoscopy

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider